Should HIV patients start drugs immediately?

A new government-funded study suggests that patients with HIV may have less risk of dying if they begin HAART, or highly active antiretroviral therapy, sooner than current guidelines currently recommend. So will the NIH fight for new guidelines to get patients on meds sooner? Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.